ImmuCell reports 2020 sales boost, new product update

ImmuCell Corp. reported a double-digit sales increase in 2020 and says it has made its last major submission to the U.S. Food and Drug Administration for a new product under development.

The Portland-based animal health products maker, which produces immunity-boosting treatments for dairy and beef cattle, reported 2020 sales of $15.3 million on Monday, up 12 percent from $13.7 million the previous year. The company suffered a net loss of $1 million, or 14 cents per share, in 2020, an improvement over its net loss of $1.3 million, or 19 cents per share, in 2019. Read more

Related Posts

On the Record: Roux Institute’s Lars Perkins helps startups take off

Lars Perkins, a former software entrepreneur, Google executive and certified flight instructor who once flew planes for lifesaving “adventure philanthropy,” is managing...

28 November 2022

UNE to begin building new medical school at Portland campus

The University of New England is about to start a $93 million project to move the state’s only medical school from...

28 November 2022

Portland Planning Board recommends zoning changes for Roux Institute redevelopment

The Portland Planning Board is recommending that the city adopt zoning changes requested by the developers of a new graduate school...

22 November 2022